CAR-T Cell Therapy Market Size, Trends & Demand 2034
CAR-T Cell Therapy Market Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Targeted Antigen (CD19 and BCMA), Indication (Lymphomas, Leukemia and Multiple Myeloma), End User (Hospitals and Specialty Clinics, Ambulatory Surgical Centers and Others), and Geography (North America, Europe, Asia Pacific, Rest of World)
- Status : Published
- Report Code : TIPRE00029935
- Category : Life Sciences
- No. of Pages : 247
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Targeted Antigen, Indication, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Treatment-center availability is critical because administration requires specialist teams, conditioning therapy, infusion capabilities, and monitoring for acute toxicities. Expansion of qualified centers can increase geographic reach and reduce travel and referral barriers for eligible patients.
The most disruptive changes could come from solid-tumor approvals, faster manufacturing, allogeneic platforms, new target antigens, and combination therapies. These developments could expand the addressable population and reduce dependence on the current CD19 and BCMA-focused treatment base.
Autologous treatment requires patient-specific production, making capacity directly connected to treatment access. Manufacturing bottlenecks can delay therapy for patients with rapidly progressing disease. Companies therefore benefit from scalable facilities, standardized workflows, and reliable logistics.
Investors should assess regulatory clarity, reimbursement, treatment-center density, domestic manufacturing capabilities, specialist availability, and patient affordability. China and India are particularly relevant because local developers and healthcare institutions are increasingly building capabilities across the cellular therapy value chain.
Commercial success depends on clinical differentiation, eligible patient volume, manufacturing reliability, treatment-center coverage, reimbursement, and speed from cell collection to infusion. Products that combine durable outcomes with predictable manufacturing and broader indications can achieve stronger utilization.
1. Executive Summary
1.1 Analyst Market Outlook
1.2 Market Attractiveness
2. CAR-T Cell Therapy Market Landscape
2.1 Overview
2.2 Value Chain Analysis
2.2.1 Raw Material Suppliers / Components
2.2.2 Manufacturers / Process / Technology
2.2.3 Distribution Landscape
2.2.4 End User
2.2.5 Level of Integration
2.3 Supply Chain Analysis
2.3.1 List of Manufacturers/Suppliers
2.3.2 List of Potential Customers
2.4 Porter`s Five Force Analysis
2.4.1 Bargaining Power of Suppliers: Moderate to High
2.4.2 Bargaining Power of Buyers: High
2.4.3 Threat of New Entrants: Moderate
2.4.4 Threat of Substitutes: Moderate
2.4.5 Competitive Rivalry: High
2.5 PEST Analysis
2.6 Impact of Artificial Intelligence (AI)
2.7 Product or Technology Roadmap
2.8 Sustainability and ESG Trends
2.8.1 Environmental Trends
2.8.2 Social Trends
2.8.3 Governance Trends
2.9 Regulatory Framework
3. Competitive Landscape
3.1 Company Benchmarking by Key Players
3.2 Market Share Analysis, 2025 – By Key Players
3.3 Market Concentration
4. CAR-T Cell Therapy Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Expansion of CAR-T Therapy into Earlier Treatment Lines and New Indications
4.1.2 Increasing Cancer Burden and High Unmet Need in Hematological Malignancies
4.1.3 Advancement of Cell Engineering and Manufacturing Technologies
4.2 Market Restraints
4.2.1 High Treatment and Manufacturing Costs
4.2.2 Complex Manufacturing and Logistical Requirements
4.2.3 Treatment-Related Toxicity and Long-Term Safety Concerns
4.3 Market Opportunities
4.3.1 CAR-T Therapy for Solid Tumors
4.3.2 Expansion into Autoimmune Diseases
4.3.3 Emerging Markets and Lower-Cost CAR-T Manufacturing
4.4 Future Trends
4.4.1 Shift Toward Allogeneic and Off-the-Shelf CAR-T
4.4.2 Emergence of In-Vivo CAR-T Therapy
4.4.3 Development of Multi-Target and Next-Generation CAR Constructs
4.5 Impact of Drivers and Restraints
5. CAR-T Cell Therapy Market – Global Market Analysis
5.1 CAR-T Cell Therapy Market Revenue (US$ Million), 2021–2034
5.2 CAR-T Cell Therapy Market Forecast and Analysis
6. CAR-T Cell Therapy Market Revenue Analysis –Targeted Antigen
6.1 CAR-T Cell Therapy Market Forecasts and Analysis by Targeted Antigen
6.1.1 CD19
6.1.1.1 Overview
6.1.1.2 CD19: CAR-T Cell Therapy Market –Revenue, 2021–2034 (US$ Million)
6.1.2 BCMA
6.1.2.1 Overview
6.1.2.2 BCMA: CAR-T Cell Therapy Market –Revenue, 2021–2034 (US$ Million)
7. CAR-T Cell Therapy Market Revenue Analysis –Indication
7.1 CAR-T Cell Therapy Market Forecasts and Analysis by Indication
7.1.1 Lymphomas
7.1.1.1 Overview
7.1.1.2 Lymphomas: CAR-T Cell Therapy Market –Revenue, 2021–2034 (US$ Million)
7.1.2 Leukemia
7.1.2.1 Overview
7.1.2.2 Leukemia: CAR-T Cell Therapy Market –Revenue, 2021–2034 (US$ Million)
7.1.3 Multiple Myeloma
7.1.3.1 Overview
7.1.3.2 Multiple Myeloma: CAR-T Cell Therapy Market –Revenue, 2021–2034 (US$ Million)
8. CAR-T Cell Therapy Market Revenue Analysis –End User
8.1 CAR-T Cell Therapy Market Forecasts and Analysis by End User
8.1.1 Hospitals and Specialty Clinics
8.1.1.1 Overview
8.1.1.2 Hospitals and Specialty Clinics: CAR-T Cell Therapy Market –Revenue, 2021–2034 (US$ Million)
8.1.2 Ambulatory Surgical Centers
8.1.2.1 Overview
8.1.2.2 Ambulatory Surgical Centers: CAR-T Cell Therapy Market –Revenue, 2021–2034 (US$ Million)
8.1.3 Others
8.1.3.1 Overview
8.1.3.2 Others: CAR-T Cell Therapy Market –Revenue, 2021–2034 (US$ Million)
9. CAR-T Cell Therapy Market – Geographical Analysis
9.1 North America
9.1.1 North America CAR-T Cell Therapy Market Overview
9.1.2 North America: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.1.3 North America: CAR-T Cell Therapy Market– By Segmentation
9.1.3.1 Targeted Antigen
9.1.3.2 Indication
9.1.3.3 End User
9.1.4 North America: CAR-T Cell Therapy Market Breakdown by Countries
9.1.4.1 United States Market
9.1.4.1.1 United States: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.1.4.1.2 United States: CAR-T Cell Therapy Market– By Segmentation
9.1.4.1.2.1 Targeted Antigen
9.1.4.1.2.2 Indication
9.1.4.1.2.3 End User
9.1.4.2 Canada Market
9.1.4.2.1 Canada: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.1.4.2.2 Canada: CAR-T Cell Therapy Market– By Segmentation
9.1.4.2.2.1 Targeted Antigen
9.1.4.2.2.2 Indication
9.1.4.2.2.3 End User
9.2 Europe
9.2.1 Europe CAR-T Cell Therapy Market Overview
9.2.2 Europe: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.3 Europe: CAR-T Cell Therapy Market– By Segmentation
9.2.3.1 Targeted Antigen
9.2.3.2 Indication
9.2.3.3 End User
9.2.4 Europe: CAR-T Cell Therapy Market Breakdown by Countries
9.2.4.1 United Kingdom Market
9.2.4.1.1 United Kingdom: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.1.2 United Kingdom: CAR-T Cell Therapy Market– By Segmentation
9.2.4.1.2.1 Targeted Antigen
9.2.4.1.2.2 Indication
9.2.4.1.2.3 End User
9.2.4.2 Germany Market
9.2.4.2.1 Germany: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.2.2 Germany: CAR-T Cell Therapy Market– By Segmentation
9.2.4.2.2.1 Targeted Antigen
9.2.4.2.2.2 Indication
9.2.4.2.2.3 End User
9.2.4.3 France Market
9.2.4.3.1 France: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.3.2 France: CAR-T Cell Therapy Market– By Segmentation
9.2.4.3.2.1 Targeted Antigen
9.2.4.3.2.2 Indication
9.2.4.3.2.3 End User
9.2.4.4 Italy Market
9.2.4.4.1 Italy: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.4.2 Italy: CAR-T Cell Therapy Market– By Segmentation
9.2.4.4.2.1 Targeted Antigen
9.2.4.4.2.2 Indication
9.2.4.4.2.3 End User
9.2.4.5 Spain Market
9.2.4.5.1 Spain: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.5.2 Spain: CAR-T Cell Therapy Market– By Segmentation
9.2.4.5.2.1 Targeted Antigen
9.2.4.5.2.2 Indication
9.2.4.5.2.3 End User
9.2.4.6 Rest of Europe Market
9.2.4.6.1 Rest of Europe: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.6.2 Rest of Europe: CAR-T Cell Therapy Market– By Segmentation
9.2.4.6.2.1 Targeted Antigen
9.2.4.6.2.2 Indication
9.2.4.6.2.3 End User
9.3 Asia Pacific
9.3.1 Asia Pacific CAR-T Cell Therapy Market Overview
9.3.2 Asia Pacific: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.3.3 Asia Pacific: CAR-T Cell Therapy Market– By Segmentation
9.3.3.1 Targeted Antigen
9.3.3.2 Indication
9.3.3.3 End User
9.3.4 Asia Pacific: CAR-T Cell Therapy Market Breakdown by Countries
9.3.4.1 China Market
9.3.4.1.1 China: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.3.4.1.2 China: CAR-T Cell Therapy Market– By Segmentation
9.3.4.1.2.1 Targeted Antigen
9.3.4.1.2.2 Indication
9.3.4.1.2.3 End User
9.3.4.2 Japan Market
9.3.4.2.1 Japan: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.3.4.2.2 Japan: CAR-T Cell Therapy Market– By Segmentation
9.3.4.2.2.1 Targeted Antigen
9.3.4.2.2.2 Indication
9.3.4.2.2.3 End User
9.3.4.3 India Market
9.3.4.3.1 India: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.3.4.3.2 India: CAR-T Cell Therapy Market– By Segmentation
9.3.4.3.2.1 Targeted Antigen
9.3.4.3.2.2 Indication
9.3.4.3.2.3 End User
9.3.4.4 Australia Market
9.3.4.4.1 Australia: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.3.4.4.2 Australia: CAR-T Cell Therapy Market– By Segmentation
9.3.4.4.2.1 Targeted Antigen
9.3.4.4.2.2 Indication
9.3.4.4.2.3 End User
9.3.4.5 South Korea Market
9.3.4.5.1 South Korea: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.3.4.5.2 South Korea: CAR-T Cell Therapy Market– By Segmentation
9.3.4.5.2.1 Targeted Antigen
9.3.4.5.2.2 Indication
9.3.4.5.2.3 End User
9.3.4.6 Rest of APAC Market
9.3.4.6.1 Rest of APAC: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.3.4.6.2 Rest of APAC: CAR-T Cell Therapy Market– By Segmentation
9.3.4.6.2.1 Targeted Antigen
9.3.4.6.2.2 Indication
9.3.4.6.2.3 End User
9.4 Rest of World
9.4.1 Rest of World CAR-T Cell Therapy Market Overview
9.4.2 Rest of World: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.4.3 Rest of World: CAR-T Cell Therapy Market– By Segmentation
9.4.3.1 Targeted Antigen
9.4.3.2 Indication
9.4.3.3 End User
10. CAR-T Cell Therapy Market Industry Landscape
11. CAR-T Cell Therapy Market – Key Company Profiles
11.1 Bristol-Myers Squibb Co
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Novartis AG
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Gilead Sciences Inc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Johnson & Johnson
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 JW (Cayman) Therapeutics Co Ltd
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Innovent Biologics Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Autolus Therapeutics Plc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Shanghai Fosun Pharmaceutical Co Ltd
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Immunoadoptive Cell Therapy Private Limited
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 CARsgen Therapeutics Holdings Limited
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 Glossary
12.2 Research Methodology and Approach
12.2.1 Secondary Research
12.2.2 Primary Research
12.2.3 Market Estimation Approach
12.2.3.1 Supply Side Analysis
12.2.3.2 Demand Side Analysis
12.2.4 Research Assumptions and Limitations
12.2.5 Currency Conversion
12.3 About The Insight Partners
12.4 Market Intelligence Cloud
List of Tables
Table 1. List of Regulatory Bodies and Organizations
Table 2. Ease of Doing Business: Key Country Rankings
Table 3. Market Share Analysis, 2025 – By Key Players
Table 4. CAR-T Cell Therapy Market – Revenue, 2021–2025(US$ Million)
Table 5. CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034(US$ Million)
Table 6. North America: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Targeted Antigen
Table 7. North America: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Targeted Antigen
Table 8. North America: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 9. North America: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 10. North America: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by End User
Table 11. North America: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by End User
Table 12. United States: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Targeted Antigen
Table 13. United States: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Targeted Antigen
Table 14. United States: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 15. United States: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 16. United States: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by End User
Table 17. United States: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by End User
Table 18. Canada: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Targeted Antigen
Table 19. Canada: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Targeted Antigen
Table 20. Canada: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 21. Canada: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 22. Canada: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by End User
Table 23. Canada: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by End User
Table 24. Europe: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Targeted Antigen
Table 25. Europe: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Targeted Antigen
Table 26. Europe: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 27. Europe: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 28. Europe: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by End User
Table 29. Europe: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by End User
Table 30. United Kingdom: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Targeted Antigen
Table 31. United Kingdom: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Targeted Antigen
Table 32. United Kingdom: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 33. United Kingdom: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 34. United Kingdom: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by End User
Table 35. United Kingdom: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by End User
Table 36. Germany: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Targeted Antigen
Table 37. Germany: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Targeted Antigen
Table 38. Germany: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 39. Germany: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 40. Germany: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by End User
Table 41. Germany: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by End User
Table 42. France: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Targeted Antigen
Table 43. France: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Targeted Antigen
Table 44. France: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 45. France: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 46. France: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by End User
Table 47. France: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by End User
Table 48. Italy: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Targeted Antigen
Table 49. Italy: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Targeted Antigen
Table 50. Italy: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 51. Italy: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 52. Italy: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by End User
Table 53. Italy: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by End User
Table 54. Spain: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Targeted Antigen
Table 55. Spain: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Targeted Antigen
Table 56. Spain: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 57. Spain: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 58. Spain: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by End User
Table 59. Spain: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by End User
Table 60. Rest of Europe: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Targeted Antigen
Table 61. Rest of Europe: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Targeted Antigen
Table 62. Rest of Europe: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 63. Rest of Europe: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 64. Rest of Europe: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by End User
Table 65. Rest of Europe: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by End User
Table 66. Asia Pacific: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Targeted Antigen
Table 67. Asia Pacific: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Targeted Antigen
Table 68. Asia Pacific: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 69. Asia Pacific: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 70. Asia Pacific: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by End User
Table 71. Asia Pacific: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by End User
Table 72. China: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Targeted Antigen
Table 73. China: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Targeted Antigen
Table 74. China: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 75. China: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 76. China: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by End User
Table 77. China: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by End User
Table 78. Japan: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Targeted Antigen
Table 79. Japan: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Targeted Antigen
Table 80. Japan: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 81. Japan: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 82. Japan: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by End User
Table 83. Japan: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by End User
Table 84. India: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Targeted Antigen
Table 85. India: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Targeted Antigen
Table 86. India: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 87. India: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 88. India: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by End User
Table 89. India: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by End User
Table 90. Australia: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Targeted Antigen
Table 91. Australia: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Targeted Antigen
Table 92. Australia: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 93. Australia: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 94. Australia: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by End User
Table 95. Australia: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by End User
Table 96. South Korea: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Targeted Antigen
Table 97. South Korea: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Targeted Antigen
Table 98. South Korea: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 99. South Korea: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 100. South Korea: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by End User
Table 101. South Korea: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by End User
Table 102. Rest of APAC: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Targeted Antigen
Table 103. Rest of APAC: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Targeted Antigen
Table 104. Rest of APAC: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 105. Rest of APAC: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 106. Rest of APAC: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by End User
Table 107. Rest of APAC: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by End User
Table 108. Rest of World: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Targeted Antigen
Table 109. Rest of World: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Targeted Antigen
Table 110. Rest of World: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 111. Rest of World: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 112. Rest of World: CAR-T Cell Therapy Market – Revenue, 2021–2025 (US$ Million) – by End User
Table 113. Rest of World: CAR-T Cell Therapy Market – Revenue Forecast, 2026–2034 (US$ Million) – by End User
Table 114. Glossary – CAR-T Cell Therapy Market
List of Figures
Figure 1. CAR-T Cell Therapy Market Segmentation
Figure 2. CAR-T Cell Therapy Market – Value Chain Analysis
Figure 3. Porter’s Five Forces Analysis
Figure 4. Pest Analysis
Figure 5. CAR-T Cell Therapy Market – Key Industry Dynamics
Figure 6. Impact Analysis of Drivers and Restraints
Figure 7. CAR-T Cell Therapy Market Revenue (US$ Million), 2021–2034
Figure 8. CAR-T Cell Therapy Market Share (%) – by Targeted Antigen (2025 and 2034)
Figure 9. CD19: CAR-T Cell Therapy Market –Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 10. BCMA: CAR-T Cell Therapy Market –Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 11. CAR-T Cell Therapy Market Share (%) – by Indication (2025 and 2034)
Figure 12. Lymphomas: CAR-T Cell Therapy Market –Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 13. Leukemia: CAR-T Cell Therapy Market –Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 14. Multiple Myeloma: CAR-T Cell Therapy Market –Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 15. CAR-T Cell Therapy Market Share (%) – by End User (2025 and 2034)
Figure 16. Hospitals and Specialty Clinics: CAR-T Cell Therapy Market –Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 17. Ambulatory Surgical Centers: CAR-T Cell Therapy Market –Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 18. Others: CAR-T Cell Therapy Market –Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 19. CAR-T Cell Therapy Market Breakdown by Geography, 2025 and 2034
Figure 20. North America: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 21. North America: CAR-T Cell Therapy Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 22. United States: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 23. Canada: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 24. Europe: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 25. Europe: CAR-T Cell Therapy Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 26. United Kingdom: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 27. Germany: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 28. France: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 29. Italy: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 30. Spain: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 31. Rest of Europe: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 32. Asia Pacific: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 33. Asia Pacific: CAR-T Cell Therapy Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 34. China: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 35. Japan: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 36. India: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 37. Australia: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 38. South Korea: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 39. Rest of APAC: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 40. Rest of World: CAR-T Cell Therapy Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 41. Bottom–Up Approach and Top–Down Approach
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For